- Previous Close
0.0000 - Open
0.1000 - Bid --
- Ask --
- Day's Range
0.1000 - 0.1000 - 52 Week Range
0.1000 - 3.4000 - Volume
4,000 - Avg. Volume
0 - Market Cap (intraday)
6.962M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8800 - Earnings Date Apr 7, 2025 - Apr 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
quantum-genomics.comRecent News: QNNTF
View MorePerformance Overview: QNNTF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QNNTF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QNNTF
View MoreValuation Measures
Market Cap
5.22M
Enterprise Value
6.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-42.65%
Return on Equity (ttm)
--
Revenue (ttm)
19
Net Income Avi to Common (ttm)
-9.4M
Diluted EPS (ttm)
-0.8800
Balance Sheet and Cash Flow
Total Cash (mrq)
704.15k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--